AI ScreeningAI ChatPricing
  1. US-listed companies
  2. Blueprint Medicines Corp
  3. Financials
  4. Common stock and paid-in capital

Blueprint Medicines Corp【BPMC】

Market cap
$8.4B
P/E ratio
SummaryFinancials
Period EndCommon stock and paid-in capital (Million USD)YoY (%)
Dec 31, 20242,709+9.51%
Dec 31, 20232,474+4.92%
Dec 31, 20222,358+4.79%
Dec 31, 20212,250+6.82%
Dec 31, 20202,107+49.18%
Dec 31, 20191,412+38.89%
Dec 31, 20181,017+3.77%
Dec 31, 2017980+132.98%
Dec 31, 2016421+50.77%
Dec 31, 2015279

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)